MAY 30, 2018 5:21 AM PDT

Non-Diet Therapy For PKU

WRITTEN BY: Nouran Amin

Phenylketonuria (PKU) is a rare inherited disorder that results an amino acid known as phenylalanine to build up in the body.

 

PKU is caused by a mutation in the gene responsible for producing the enzyme needed to break down phenylalanine. Without the enzyme, a toxic buildup can develop for individuals with PKU when they ingest foods that contain protein or aspartame; eventually leading to serious health complications. Babies born in the United States and many other countries are screened for PKU after birth, in order to recognize it right away and avoid any major health problems. For the rest of their lives, individuals with PKU — babies, children, and adults — must follow a strict diet that is phenylalanine-free.

Until this most recently, one of the only non-diet treatment options for individuals of PKU consisted of replacement cofactor; BioMarin’s Kuvan (sapropterin dihydrochloride). Kuvan binds to and enhances the activity of phenylalanine hydroxylase (PAH), an enzyme that metabolizes phenylalanine. “While Kuvan has been helpful to some people, it doesn't really benefit the large portion of our community, and many of those people are still struggling,” states Christine Brown, executive director of the National PKU Alliance (NPKUA), a nonprofit patient advocacy group, and the mother of two boys with PKU, “For most people, even on Kuvan, they still have to take medical foods.” Now, the FDA has recently approved another non-diet therapy: an enzyme substitute known as pegvaliase (Palynziq).

Palynziq metabolizes phenylalanine, replacing the deficient PAH enzyme that in PKU patients. “It is great that the FDA has approved . . . [Palynziq],” writes Francjan van Spronsen, a pediatrician specializing in inherited metabolic diseases at the University of Groningen in the Netherlands. “We have heard very promising results [that patients’] whole lives have changed, as now at least some of them can do without [specialized] diets or have increased their phenylalanine tolerance to a large degree.” As of now, Palynziq is only approved for use in the U.S and only for adult patients with uncontrolled phenylalanine amounts. Palynziq also comes with a black box warning due to the risk of anaphylaxis, which is severe and may be fatal allergic reaction if not treated. BioMarin has stated has announced that the therapy is expected to cost approximately $192,000 per year.

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
NOV 08, 2020
Drug Discovery & Development
Psychedelic Mushrooms Effectively Treat Major Depression
NOV 08, 2020
Psychedelic Mushrooms Effectively Treat Major Depression
Over 17 million people in the US and 300 million people worldwide are estimated to have experienced major depression. No ...
NOV 17, 2020
Immunology
6 Injections a Year Prevent HIV Infections
NOV 17, 2020
6 Injections a Year Prevent HIV Infections
Last year, around 1.7 million people became infected with HIV, with around half of these being women. Encouraging result ...
NOV 15, 2020
Drug Discovery & Development
Antidepressant May Prevent Worsening of COVID-19 Infections
NOV 15, 2020
Antidepressant May Prevent Worsening of COVID-19 Infections
  Researchers from the Washington University School of Medicine in St. Louis have found that fluvoxamine, a common ...
NOV 26, 2020
Cannabis Sciences
Women More Likely than Men to Swap Prescription Medication for Cannabis
NOV 26, 2020
Women More Likely than Men to Swap Prescription Medication for Cannabis
The stigma around cannabis usage is fading as cannabis laws become increasingly lax. Now, researchers from DePaul Univer ...
DEC 30, 2020
Neuroscience
Do Psychedelics Reduce Trauma from Racial Injustice?
DEC 30, 2020
Do Psychedelics Reduce Trauma from Racial Injustice?
Researchers from Ohio State University have found that a single positive experience on psychedelics may reduce stress, d ...
JAN 02, 2021
Drug Discovery & Development
Drug Re-purposed for COVID-19
JAN 02, 2021
Drug Re-purposed for COVID-19
Pralatrexate, a chemotherapeutic drug originally developed to treat lymphoma, could be repurposed to treat COVID-19&mdas ...
Loading Comments...